Skip to content

Clinical trials

Phase 1 trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1 Country / region: Hong Kong Clear all

144 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20064
20072
20081
20095
20106
20113
20124
20135
20145
20159
20165
201710
201815
20197
202011
202111
20229
20236
20249
202511
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed85
Terminated18
Recruiting16
Active, not recruiting13
Unknown status5
Not yet recruiting4
Withdrawn2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals24
Hoffmann-La Roche13
The University of Hong Kong10
Amgen8
Chinese University of Hong Kong6
GlaxoSmithKline6
AstraZeneca5
Lee's Pharmaceutical Limited4
Boehringer Ingelheim3
The Hong Kong Polytechnic University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B, Chronic22
Carcinoma, Non-Small-Cell Lung14
Neoplasms13
Hepatitis B11
Carcinoma, Hepatocellular9
Breast Neoplasms5
Colorectal Neoplasms5
Liver Neoplasms5
Lymphoma, Non-Hodgkin4
Pancreatic Neoplasms4

Trials

Showing 51 to 75 of 144. Each trial links to its page on Pharma Observatory.

44 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.